Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Clinical and Experimental Immunology
|
December 30, 2014
Considering the demand for and prioritization of intravenous immunoglobulin
J S Orange
Research in Immunology
|
September 1, 1995
IL12 in acute viral infectious disease
C A Biron, J S Orange
Cellular and Molecular Life Sciences : CMLS
|
August 1, 2008
Cell penetrating peptide inhibitors of nuclear factor-kappa B
J S Orange, M J May
Journal of Immunology (Baltimore, Md. : 1950)
|
June 15, 1996
Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection
J S Orange, C A Biron
Journal of Immunology (Baltimore, Md. : 1950)
|
February 1, 1996
An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections
J S Orange, C A Biron
Vox Sanguinis
|
April 21, 2018
Latent therapeutic demand model for the immunoglobulin replacement therapy of primary immune deficiency disorders in the USA
J S Stonebraker, J Hajjar, J S Orange
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1995
Endogenous IL-2 contributes to T cell expansion and IFN-gamma production during lymphocytic choriomeningitis virus infection
L P Cousens, J S Orange, C A Biron
Journal of Immunology (Baltimore, Md. : 1950)
|
February 1, 1994
Effects of IL-12 on the response and susceptibility to experimental viral infections
J S Orange, S F Wolf, C A Biron
The Journal of Experimental Medicine
|
January 31, 1998
Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways
T P Salazar-Mather, J S Orange, C A Biron
The Journal of Experimental Medicine
|
October 1, 1995
Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration
J S Orange, B Wang, C Terhorst, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Clinical and Experimental Immunology
|
December 30, 2014
Considering the demand for and prioritization of intravenous immunoglobulin
J S Orange
Research in Immunology
|
September 1, 1995
IL12 in acute viral infectious disease
C A Biron, J S Orange
Cellular and Molecular Life Sciences : CMLS
|
August 1, 2008
Cell penetrating peptide inhibitors of nuclear factor-kappa B
J S Orange, M J May
Journal of Immunology (Baltimore, Md. : 1950)
|
June 15, 1996
Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection
J S Orange, C A Biron
Journal of Immunology (Baltimore, Md. : 1950)
|
February 1, 1996
An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections
J S Orange, C A Biron
Vox Sanguinis
|
April 21, 2018
Latent therapeutic demand model for the immunoglobulin replacement therapy of primary immune deficiency disorders in the USA
J S Stonebraker, J Hajjar, J S Orange
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1995
Endogenous IL-2 contributes to T cell expansion and IFN-gamma production during lymphocytic choriomeningitis virus infection
L P Cousens, J S Orange, C A Biron
Journal of Immunology (Baltimore, Md. : 1950)
|
February 1, 1994
Effects of IL-12 on the response and susceptibility to experimental viral infections
J S Orange, S F Wolf, C A Biron
The Journal of Experimental Medicine
|
January 31, 1998
Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways
T P Salazar-Mather, J S Orange, C A Biron
The Journal of Experimental Medicine
|
October 1, 1995
Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration
J S Orange, B Wang, C Terhorst, et al.
Page
of 3